The MS-LINK™ Outcomes Study

Completed

Conditions studied: Multiple Sclerosis

In brief

The Multiple Sclerosis (MS) Leadership and Innovation Network (MS-LINK™) is comprised of networks working cooperatively to advance Multiple Sclerosis (MS) science and improve MS participant outcomes. In this study participants will be followed from the time of consent through the lifetime of the study (currently 3 years), unless the participant chooses to withdraw from the study. Collection of participant's medical history, including MS and treatment history, will be automated through extraction from the participant's electronic medical record (EMR) and other health information systems (for example, radiology). Participants will complete patient-reported outcomes (PROs) and other health-related information digitally. Participating participants will have access to their own data in an ongoing manner via a web-based Participant Portal.

Key facts

Study ID

NCT04735406

Run by

EMD Serono Research & Development Institute, Inc.

People needed

2182

Starts

2021-03-24

Expected to finish

2024-05-31

Last updated by the study team

2024-08-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants willing and able to provide written informed consent
• Participants willing to be contacted while participating in the study for recruitment into sub-studies that may be relevant to them
• Participants willing and able to complete PROs on a monthly basis and document events of interest as they occur
• Participants willing to participate in additional follow up at the site for at least three years

You may not qualify if…

• Unable to complete questionnaires in English
• Unable to consistently access the Internet
• Participants participating in interventional clinical drug trials at baseline

Where it is running

• Alabama Neurology Associates — Birmingham, Alabama, United States
• Georgetown University — Washington D.C., District of Columbia, United States
• Atlanta Neuroscience Institute — Atlanta, Georgia, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• Memorial healthcare — Owosso, Michigan, United States
• University of Nebraska medical Center — Omaha, Nebraska, United States
• The Oklahoma Medical Research Foundation — Oklahoma City, Oklahoma, United States
• The University of Texas of Austin — Austin, Texas, United States
• University of Texas Health — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.